Cardiomyopathy pathophysiology: Difference between revisions

Jump to navigation Jump to search
Created page with "{{Cardiomyopathy}} {{CMG}} ==Gross Pathological Findings== [http://www.peir.net Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission..."
 
Line 113: Line 113:
</gallery>
</gallery>
</div>
</div>
==Microscopic Pathological Findings==
[http://www.peir.net Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology]
<div align="left">
<gallery heights="175" widths="175">
Image:438.jpg|Cardiomyopathy: Micro H&E high mag excellent example myofiber disarray
Image:439.jpg|Cardiomyopathy: Micro H&E low mag interventricular septum at junction of normal myofiber orientation with asymmetrical hypertrophy (an excellent example)
</gallery>
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:432.jpg|Cardiomyopathy: Micro trichrome low mag bizarre vacuolated fibers with disarray and focal fibrosis excellent low mag epicardial surface
Image:666.jpg|Alcoholic Cardiomyopathy: Micro plastic section lipid in perinuclear area loss of myofibrils
</gallery>
</div>
==References==
{{Reflist|2}}
[[Category: Cardiology]]
[[Category: Up-To-Date]]
[[Category: Up-To-Date Cardiology]]
{{WH}}
{{WS}}

Revision as of 17:14, 16 October 2011

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy pathophysiology

CDC on Cardiomyopathy pathophysiology

Cardiomyopathy pathophysiology in the news

Blogs on Cardiomyopathy pathophysiology

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Gross Pathological Findings

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology












Microscopic Pathological Findings

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology


References

Template:WH Template:WS